Cargando…

A New Potential Contrast Agent for Magnetic Resonance Imaging: Iron Oxide-4A Nanocomposite

BACKGROUND: Magnetic resonance imaging (MRI) contrast agents have an important role to differentiate healthy and diseased tissues. Access and design new contrast agents for the optimal use of MRI are necessary. This study aims to evaluate iron oxide-4A nanocomposite ability to act as a magnetic reso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zareei, L., Divband, B., Mesbahi, A., Khatamian, M., Kiani, A., Gharehaghaji, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Biomedical Physics and Engineering 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538918/ https://www.ncbi.nlm.nih.gov/pubmed/31214526

Ejemplares similares

Magnetic Resonance Imaging Property of Doxorubicin-Loaded Gadolinium/13X Zeolite/Folic Acid Nanocomposite
por: S., Ghaderi, et al.
Publicado: (2020)

PEGylated Magnetite/Hydroxyapatite: A Green Nanocomposite for T2-Weighted MRI and Curcumin Carrying
por: Gharehaghaji, Nahideh, et al.
Publicado: (2022)

Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents
por: Gervits, Natalia E, et al.
Publicado: (2019)

Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging
por: Bae, Hongsub, et al.
Publicado: (2012)

The Effect of Inversion Time on the Relationship Between Iron Oxide Nanoparticles Concentration and Signal Intensity in T1-Weighted MR Images
por: Saharkhiz, Hodaiseh, et al.
Publicado: (2014)

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging
por: Hachani, Roxanne, et al.
Publicado: (2017)

Effect of Neodymium Doping on MRI Relaxivity of Gadolinium Oxide Nanoparticles
por: B., Divband, et al.
Publicado: (2020)

Gadolinium-labelled iron/iron oxide core/shell nanoparticles as T(1)–T(2) contrast agent for magnetic resonance imaging
por: Wang, Kaili, et al.
Publicado: (2018)

Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer
por: Zhang, He, et al.
Publicado: (2016)

Iron oxide nanoparticles as positive T(1) contrast agents for low-field magnetic resonance imaging at 64 mT
por: Oberdick, Samuel D., et al.
Publicado: (2023)

Gd-Si Oxide Nanoparticles as Contrast Agents in Magnetic Resonance Imaging
por: Cabrera-García, Alejandro, et al.
Publicado: (2016)

The effect of zinc oxide nanoparticles deposition for friction reduction on orthodontic wires
por: Kachoei, Mojghan, et al.
Publicado: (2013)

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

Label-Free Iron Oxide Nanoparticles as Multimodal Contrast Agents in Cells Using Multi-Photon and Magnetic Resonance Imaging
por: Reynders, Hendrik, et al.
Publicado: (2021)

Mn(ii) chelate-coated superparamagnetic iron oxide nanocrystals as high-efficiency magnetic resonance imaging contrast agents
por: Wu, Changqiang, et al.
Publicado: (2020)

Engineered Protein-Driven Synthesis of Tunable Iron Oxide Nanoparticles as T1 and T2 Magnetic Resonance Imaging Contrast Agents
por: Aires, Antonio, et al.
Publicado: (2022)

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

Exendin-4-Conjugated Manganese Magnetism-Engineered Iron Oxide Nanoparticles as a Potential Magnetic Resonance Imaging Contrast Agent for Tracking Transplanted β-Cells
por: Juang, Jyuhn-Huarng, et al.
Publicado: (2021)

In situ self-assembly of amphiphilic dextran micelles and superparamagnetic iron oxide nanoparticle-loading as magnetic resonance imaging contrast agents
por: Jiang, Linrui, et al.
Publicado: (2022)

pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
por: Huang, Xi, et al.
Publicado: (2018)

Dynamically switchable magnetic resonance imaging contrast agents
por: Wang, Qiyue, et al.
Publicado: (2021)

Contrast Agents of Magnetic Resonance Imaging and Future Perspective
por: Lv, Jie, et al.
Publicado: (2023)

Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013)

Concurrent Dual Contrast for Cellular Magnetic Resonance Imaging Using Gadolinium Oxide and Iron Oxide Nanoparticles
por: Loai, Yasir, et al.
Publicado: (2012)

Activatable T(1) and T(2) Magnetic Resonance Imaging Contrast Agents
por: Tu, Chuqiao, et al.
Publicado: (2011)

Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging
por: Bales, Brian C., et al.
Publicado: (2019)

Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging
por: Bates, David, et al.
Publicado: (2014)

Pluronic F127-Folate Coated Super Paramagenic Iron Oxide Nanoparticles as Contrast Agent for Cancer Diagnosis in Magnetic Resonance Imaging
por: Vu-Quang, Hieu, et al.
Publicado: (2019)

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger, Harald, et al.
Publicado: (2017)

Magnetic resonance and ultrasound contrast imaging of polymer-shelled microbubbles loaded with iron oxide nanoparticles
por: Sciallero, Claudia, et al.
Publicado: (2016)

Evaluation of Microbubbles as Contrast Agents for Ultrasonography and Magnetic Resonance Imaging
por: Li, Ling, et al.
Publicado: (2012)

Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging
por: Pellico, Juan, et al.
Publicado: (2019)

Iron phosphide nanoparticles as a pH-responsive T(1) contrast agent for magnetic resonance tumor imaging
por: Qiu, Yuan, et al.
Publicado: (2019)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

Oxidation-Responsive, Eu(II/III)-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging
por: Basal, Lina A., et al.
Publicado: (2017)

Correlating Magnetic Hyperthermia and Magnetic Resonance Imaging Contrast Performance of Cubic Iron Oxide Nanoparticles with Crystal Structural Integrity
por: Shingte, Sameer D., et al.
Publicado: (2022)

Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque
por: Evans, Rhiannon J., et al.
Publicado: (2020)

Dosimetry of Critical Organs in Maxillofacial Imaging with Cone-beam Computed Tomography
por: Ghanbarnezhad Farshi, R., et al.
Publicado: (2019)

Development of New Contrast Agents for Imaging Function and Metabolism by Magnetic Resonance Imaging
por: Carvalho, Alexandra, et al.
Publicado: (2017)

Modified Nanoemulsions with Iron Oxide for Magnetic Resonance Imaging
por: Fan, Yongyi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gl3baht7ta82inktikcrpshhg3